Rituximab Treatment for Relapsing Minimal Change Disease and Focal Segmental Glomerulosclerosis: A Systematic Review

Renal involvement in autoimmune connective tissue diseases

(2013) Andreas Kronbichler et al.   BMC Medicine

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

(2013) Helene Munyentwali et al.   KIDNEY INTERNATIONAL

Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases

(2013) Andreas Kronbichler et al.   WIENER KLINISCHE WOCHENSCHRIFT

Rituximab mediates loss of CD19 on B cells in the absence of cell death

(2012) Jonathan D. Jones et al.   ARTHRITIS AND RHEUMATISM

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis

(2012) Ayami Ochi et al.   INTERNAL MEDICINE

Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature

(2012) Wai Yew Kong et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Extending Prednisolone Treatment Does Not Reduce Relapses in Childhood Nephrotic Syndrome

(2012) N. Teeninga et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab in Idiopathic Membranous Nephropathy

(2012) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults

(2012) T. Takei et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab Treatment for Adults with Refractory Nephrotic Syndrome: A Single-Center Experience and Review of the Literature

(2012) Tuelay Kisner et al.   NEPHRON CLINICAL PRACTICE

Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?

(2012) Laëtitia Delbe-Bertin et al.   PEDIATRIC NEPHROLOGY

Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome

(2012) Mai Sato et al.   PEDIATRIC NEPHROLOGY

Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome

(2012) Shuichi Ito et al.   PEDIATRIC NEPHROLOGY

Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome

(2011) Nobuyuki Amemiya et al.   Clinical and Experimental Nephrology

Successful therapeutic use of a single-dose of rituximab on relapse in adults with minimal change nephrotic syndrome

(2011) Y. Sawara et al.   CLINICAL NEPHROLOGY

Rituximab in adult patients with immunosuppressive-dependent minimal change disease

(2011) E. Hoxha et al.   CLINICAL NEPHROLOGY

Neutropenia after rituximab treatment

(2011) Ofir Wolach et al.   CURRENT OPINION IN HEMATOLOGY

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab

(2011) Rodrigo Cartin-Ceba et al.   CURRENT OPINION IN RHEUMATOLOGY

Clinical trial of focal segmental glomerulosclerosis in children and young adults

(2011) Debbie S. Gipson et al.   KIDNEY INTERNATIONAL

Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery

(2011) A.-L. Sellier-Leclerc et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome

(2011) M. J. Kemper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients

(2011) M Wendt et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

(2011) A. Fornoni et al.   Science Translational Medicine

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

(2010) J.-E. Gottenberg et al.   ARTHRITIS AND RHEUMATISM

Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

(2010) F. C. Fervenza et al.   Clinical Journal of the American Society of Nephrology

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome: Multicentric Report

(2010) A. Gulati et al.   Clinical Journal of the American Society of Nephrology

Prevention and treatment of systemic glucocorticoid side effects

(2010) Siamak Moghadam-Kia et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection

(2010) K. Sakai et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis

(2009) G. Fernandez-Fresnedo et al.   Clinical Journal of the American Society of Nephrology

Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome

(2009) Noritomo Kurosu et al.   INTERNAL MEDICINE

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

Rituximab in refractory nephrotic syndrome

(2009) Agnieszka Prytuła et al.   PEDIATRIC NEPHROLOGY

Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature

(2009) Martin Bitzan et al.   PEDIATRIC PULMONOLOGY

Short- and long-term efficacy of levamisole as adjunctive therapy in childhood nephrotic syndrome

(2008) Olivia Boyer et al.   PEDIATRIC NEPHROLOGY

Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome

(2008) Viktória Sümegi et al.   PEDIATRIC NEPHROLOGY

Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases

(2008) Vincent Guigonis et al.   PEDIATRIC NEPHROLOGY

Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells

(2008) Syamal K Datta   Nature clinical practice. Rheumatology